T cell epitope-containing peptides of the major dog allergen Can f 1 as candidates for allergen immunotherapy

J Immunol. 2005 Sep 15;175(6):3614-20. doi: 10.4049/jimmunol.175.6.3614.

Abstract

One prerequisite for developing peptide-based allergen immunotherapy is knowing the T cell epitopes of an allergen. In this study, human T cell reactivity against the major dog allergen Can f 1 was investigated to determine peptides suitable for immunotherapy. Seven T cell epitope regions (A-G) were found in Can f 1 with specific T cell lines and clones. The localization of the epitope regions shows similarities with those of the epitopes found in Bos d 2 and Rat n 1. On average, individuals recognized three epitopes in Can f 1. Our results suggest that seven 16-mer peptides (p15-30, p33-48, p49-64, p73-88, p107-122, p123-138, and p141-156), each from one of the epitope regions, show widespread T cell reactivity in the population studied, and they bind efficiently to seven HLA-DRB1 molecules (DRB1*0101, DRB1*0301, DRB1*0401, DRB1*0701, DRB1*1101, DRB1*1301, and DRB1*1501) predominant in Caucasian populations. Therefore, these peptides are potential candidates for immunotherapy of dog allergy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allergens / immunology*
  • Allergens / therapeutic use
  • Animals
  • Antigens, Plant
  • Cells, Cultured
  • Dogs
  • Epitope Mapping
  • Epitopes, T-Lymphocyte / immunology*
  • HLA-DR Antigens / immunology
  • HLA-DRB1 Chains
  • Humans
  • Hypersensitivity / therapy
  • Immunotherapy / methods*
  • Peptide Fragments / immunology*
  • Peptide Fragments / therapeutic use
  • T-Lymphocytes / cytology
  • T-Lymphocytes / immunology*

Substances

  • Allergens
  • Antigens, Plant
  • Epitopes, T-Lymphocyte
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • HLA-DRB1*03:01 antigen
  • HLA-DRB1*04:01 antigen
  • Peptide Fragments
  • allergen Can f I